Teva Pharmaceutical Industries Ltd.’s new chief executive is shuffling the company’s leadership ranks and combining its generic and specialty businesses as he embarks on a turnaround plan at the struggling drugmaker.
from WSJ.com: US Business http://ift.tt/2BgX7lF
via IFTTT
No comments:
Post a Comment